-transparent.png){kind=logo}
The mechanism of the inhibitory effect of pranoprofen on sodium urate crystal-induced inflammation was investigated with several inflammatory parameters using leucocytes stimulated with sodium urate crystals in vitro. At 10(-5) M, pranoprofen tended to inhibit the production of chemotactic factor in guinea pig polymorphonuclear leucocytes (PMNL) stimulated with sodium urate crystals and at 10(-4) M, significantly inhibited it. At 10(-3) M and 10(-4) M, it potentiated the chemotaxis of guinea pig PMNL. Furthermore, it inhibited the production of superoxide anion (O2-) in guinea pig PMNL stimulated with sodium urate crystals, with an IC50 value of 5.0 X 10(-4) M, comparable to that of indomethacin. At 10(-3) M, it inhibited the release of beta-glucuronidase stimulated by sodium urate crystals. From doses as low as 10(-6) M, it inhibited dose-dependently the production of PGE2-like substance by the phagocytosis of sodium urate crystals by rat peritoneal leucocytes, with an IC50 value of 7.5 X 10(-6) M. These results suggest that in inhibiting the production of PGE2 stimulated by sodium urate crystals, pranoprofen shows an inhibitory effect on sodium urate crystal-induced inflammation.
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
December 1991,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
January 2018,
Frontiers in immunology,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
January 1972,
Arthritis and rheumatism,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
January 1974,
Pharmacology,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
October 2018,
Cytokine,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
May 2008,
Cytokine,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
April 1997,
Inflammation,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
August 2012,
The Journal of pharmacy and pharmacology,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
January 1970,
Pharmacology,
H Aratani, and
Y Iwahisa, and
T Imayoshi, and
Y Nagaoka, and
M Terasawa, and
Y Maruyama
January 2008,
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
